Literature DB >> 12004312

Skin cancer screening by dermatologists: prevalence and barriers.

Daniel G Federman1, Jeffrey D Kravetz, Robert S Kirsner.   

Abstract

BACKGROUND: The incidence of skin cancers is increasing at an alarming rate, and there is currently no consensus by major health policy organizations regarding skin cancer screening. It has previously been shown that primary care physicians do not screen a majority of patients for skin cancer.
OBJECTIVE: This study was undertaken to determine the prevalence of skin cancer screening among dermatologists and to detect barriers to screening. As a secondary objective, we set out to determine the prevalence of dermatoscopy use.
METHODS: With the use of membership data from the 1999-2000 directory of the American Academy of Dermatology, a random sample of 464 American dermatologists was surveyed to assess their skin cancer screening practices and perceived obstacles to this practice. We then determined whether differences in knowledge of skin cancer screening recommendations, emphasis of skin cancer screening in training, or physician age affected the prevalence of screening.
RESULTS: A total of 190 dermatologists responded (41%). Fifty-seven respondents (30%) reported performing full-body skin cancer screening on all of their adult patients and 93 more (49%) reported screening only patients perceived to be at increased risk. Eighty respondents (42%) reported lack of time as an impediment to screening. Only 18 (9%) did not screen patients because of potential patient embarrassment, whereas 17 (9%) did not perform screening because of lack of financial reimbursement. Sixty-two dermatologists (33%) reported being aware of official skin cancer screening recommendations, but they were not more likely to screen all patients (P =.64) or partake in screening of all patients or only those at increased risk (P =.84). One hundred nineteen respondents (63%) reported that skin cancer screening was emphasized during their medical training and they were more likely to screen all patients (P =.04) or either all or high-risk patients (P =.02). Younger age groups of dermatologists were significantly more likely to screen all patients for skin cancer (P =.03). Twenty-two percent of respondents reported using dermatoscopy for suspicious lesions.
CONCLUSION: Dermatologists report a high rate of screening for skin cancer despite not having knowledge of skin cancer screening recommendations. Inadequate time to perform full-body skin examinations and lack of emphasis during training were identified as possible barriers to this practice.

Entities:  

Mesh:

Year:  2002        PMID: 12004312     DOI: 10.1067/mjd.2002.120531

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  19 in total

Review 1.  Strategies for early melanoma detection: Approaches to the patient with nevi.

Authors:  Agnessa Gadeliya Goodson; Douglas Grossman
Journal:  J Am Acad Dermatol       Date:  2009-05       Impact factor: 11.527

2.  Reported skin cancer screening of US adult workers.

Authors:  William G LeBlanc; Liat Vidal; Robert S Kirsner; David J Lee; Alberto J Caban-Martinez; Kathryn E McCollister; Kristopher L Arheart; Katherine Chung-Bridges; Sharon Christ; John Clark; John E Lewis; Evelyn P Davila; Panta Rouhani; Lora E Fleming
Journal:  J Am Acad Dermatol       Date:  2008-04-24       Impact factor: 11.527

3.  Patient-reported frequency of acral surface inspection during skin examination in white and ethnic minority patients.

Authors:  Monica S Tsai; Melvin W Chiu
Journal:  J Am Acad Dermatol       Date:  2014-04-24       Impact factor: 11.527

4.  The Impact of Obesity on Surgically Treated Locoregional Melanoma.

Authors:  Constance S Harrell Shreckengost; Marvi Tariq; Clara R Farley; Chao Zhang; Keith A Delman; Ragini R Kudchadkar; Michael C Lowe
Journal:  Ann Surg Oncol       Date:  2021-03-14       Impact factor: 5.344

5.  Prevalence and correlates of skin cancer screening among middle-aged and older white adults in the United States.

Authors:  Elliot J Coups; Alan C Geller; Martin A Weinstock; Carolyn J Heckman; Sharon L Manne
Journal:  Am J Med       Date:  2010-05       Impact factor: 4.965

Review 6.  Survival is not the only valuable end point in melanoma screening.

Authors:  Clara Curiel-Lewandrowski; Caroline C Kim; Susan M Swetter; Suephy C Chen; Allan C Halpern; John M Kirkwood; Sancy A Leachman; Ashfaq A Marghoob; Michael E Ming; James M Grichnik
Journal:  J Invest Dermatol       Date:  2012-02-16       Impact factor: 8.551

Review 7.  Screening and early detection of skin cancer.

Authors:  Kenneth G Linden
Journal:  Curr Oncol Rep       Date:  2004-11       Impact factor: 5.075

Review 8.  Screening and prevention measures for melanoma: is there a survival advantage?

Authors:  Clara Curiel-Lewandrowski; Suephy C Chen; Susan M Swetter
Journal:  Curr Oncol Rep       Date:  2012-10       Impact factor: 5.075

9.  Melanoma screening by means of complete skin exams for all patients in a dermatology practice reduces the thickness of primary melanomas at diagnosis.

Authors:  Anthony J Chiaravalloti; Jeffrey R Laduca
Journal:  J Clin Aesthet Dermatol       Date:  2014-08

10.  Assisting Main Task Learning by Heterogeneous Auxiliary Tasks with Applications to Skin Cancer Screening.

Authors:  Ning Situ; Xiaojing Yuan; George Zouridakis
Journal:  J Mach Learn Res       Date:  2011-01-01       Impact factor: 3.654

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.